Abstract

Formulation Optimization Study for an Immediate-Release Tablet

Author(s): Kyriacos Soula, Dimassi Hani

Issue: May/Jun 2009 - Pain Management

Page(s): 259-261

Download in electronic PDF format for $75
  • Formulation Optimization Study for an Immediate-Release Tablet Page 1
  • Formulation Optimization Study for an Immediate-Release Tablet Page 2
  • Formulation Optimization Study for an Immediate-Release Tablet Page 3

Abstract

A simple method based on statistical analysis was used to optimize an immediate-release tablet formulation that includes a water-soluble drug. The objective of this study was to optimize different factors to develop a tablet formulation that has good tablet characteristics (hardness of 85 to 90 Newtons), disintegration time between 3 to 6 minutes, and friability <1%. The critical formulation/process factors were the type and concentration of microcrystalline cellulose, the ratio of lactose to microcrystalline cellulose, the concentration of croscarmellose, and the compression force. A two-step approach was implemented. First an optimization study was performed to determine the type of microcrystalline cellulose and its ratio to lactose. Subsequently, a final optimization formulation study was performed based on the results obtained in the preliminary study. Data were analyzed using the SPSS 15 (Statistical Software for Social Sciences). The differences in means between the formulation and the targeted product

Related Keywords

  • water-soluble drugs
  • immediate release
  • formulation development
  • excipients

Related Categories

  • EXCIPIENTS
  • PEER-REVIEWED
  • QUALITY CONTROL
  • DOSAGE FORMS/DRUG CARRIERS

Printer-Friendly Version

Related Articles from IJPC

Issue/Page
View/Buy		 Title/Author
(Click for Abstract / Details / Purchase)
May/Jun 2009
Pg. 259-261
Formulation Optimization Study for an Immediate-Release Tablet
Author(s): Kyriacos Soula, Dimassi Hani
Sep/Oct 2021
Pg. 364-371
Filling the Gaps on the Institute for Safe Medication Practices (ISMP) Do Not Crush List for Immediate-release Products
Author(s): Uttaro Elizabeth, Zhao Fang, Schweighardt Anne
Jan/Feb 2011
Pg. 81-84
Stability of Venlafaxine Immediate-Release Suspensions
Author(s): Donnelly Ronald F, Wong Keith, Goddard Rob, Johanson Christel
Sep/Oct 2017
Pg. 418-425
Kinetic Analysis of Drug Release from Compounded Slow-release Capsules of Liothyronine Sodium (T3)
Author(s): Bakhteyar Hamid, Cassone Clayton, Kohan Hamed Gilzad, Sani Shabnam N
Sep/Oct 2001
Pg. 401-405
Release of Morphine Sulfate from Compounded Slow-Release Capsules: The Effect of Formulation on Release
Author(s): Bogner Robin H, Szwejkowski Jessica, Houston Alana
Sep/Oct 2023
Pg. 431-439
The Influence of Polymers, Surfactants, and Other Excipients on Naproxen Sodium Release from Matrices Prepared and the Effect of These Additives on the Swelling Rate of the Tablet
Author(s): Alhmoud Hassan, Akkam Yazan, Omari Derar, Alghananim Alaa, Melhem Mohammad Bani
Jan/Feb 2013
Pg. 10-22
Compounding Slow-release Capsules: A Comprehensive Review and an Excel Spreadsheet for Faster Calculation of Excipients
Author(s): Zur Eyal
Sep/Oct 2019
Pg. 399-402
Sterile Basics: Pharmaceutical Waters Used in Sterile and Nonsterile Compounding
Author(s): Allen Loyd V Jr
Mar/Apr 2011
Pg. 175
Erratum: Stability of Venlafaxine Immediate-Release Suspensions
Author(s): Allen Loyd V Jr
Sep/Oct 2013
Pg. 424-431
In Vitro Evaluation of Extemporaneously Compounded Immediate-release Capsules with Premixed Excipients, Based on the Biopharmaceutics Classification System (BCS) of the Drugs
Author(s): Pinheiro Vanessa A, Danopoulos Panagiota, Demirdjian Lara, Nogueira Rodrigo J L, Dubois Fanny
May/Jun 2003
Pg. 233-239
Formulation Development and Stability Testing of Extemporaneous Suspension Prepared From Dapsone Tablets
Author(s): Kaila Nitin, El-Ries Mohamed, Riga A, Alexander Kenneth S, Dollimore D
May/Jun 2011
Pg. 224-232
Quality Control Analytical Methods: Aqua Pura: Water Purification Systems and United States Pharmacopeia Waters for the Compounding Pharmacy, Part 2: USP Waters: Experts at the United States Pharmacopeia Answer Compounders' Questions
Author(s): Schnatz Rick, Hernandex-Cardoso Antonio
Nov/Dec 2022
Pg. 516-521
Formulation Development of Modafinil Sprinkle Dosage Form: Study on the Effect of Food on Dosage
Author(s): Kumaravelrajan Rajagopal, Karthik B, Venkatasan Suba
Sep/Oct 2024
Pg. 364-372
Crushability Analysis of Immediate-Release Oral Tablets and Capsules from the 2020-22 FDA Novel Drug Approvals
Author(s): Saei Kamaladdin, Schweighardt Anne, Zhao Fang
Jan/Feb 2023
Pg. 60-71
Formulation, Evaluation, and Characterization of Ibuprofen Nanocrystals Tablets with Conventional Market Product
Author(s): Chauhan Nikita N, Patel Jayvadan K
Mar/Apr 2008
Pg. 163-169
Pharmaceutical Development of Enteric-Release Hard Gelatin Capsules in the Compounding Setting
Author(s): de Oliveira Ferreira Anderson, Holandino Carla
Sep/Oct 1999
Pg. 409-411
In Vitro Studies on the Release of Morphine Sulfate from Compounded Slow-Release Morphine-Sulfate Capsules
Author(s): Webster Kathy D, Al-Achi Antoine, Greenwood Robert
Jan/Feb 2022
Pg. 80-87
Investigation of the Effects of Excipients in the Compounding of Amlodipine Besylate Orally Disintegrating Tablets
Author(s): Azmi Nurual Hanisah Saiful, Ming Long Chiau, Uddin ABM Helal, Sarker Zaidul Islam, Bin Liew Kai
Jul/Aug 2021
Pg. 304-309
Basics of Compounding: Excipients Used in Nonsterile Compounding, Part 10: Rectal Suppository Bases
Author(s): Allen Loyd V Jr
Sep/Oct 2017
Pg. 388-392
Basics of Compounding: 3D Printing--Pharmacy Applications: Geometric Shape Effects on 3D Printing
Author(s): Allen Loyd V Jr